{"id":50173,"date":"2022-10-27T16:02:08","date_gmt":"2022-10-27T14:02:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/"},"modified":"2022-10-27T16:02:08","modified_gmt":"2022-10-27T14:02:08","slug":"genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/","title":{"rendered":"Genoox partners with Thermo Fisher Scientific to automate cytogenetic research data interpretation and reporting with AI"},"content":{"rendered":"
\n

PALO ALTO, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific has upgraded its leading Applied Biosystems Chromosome Analysis Suite (ChAS) software through a collaboration with Genoox, a community-driven genomic data company. ChAS users will be able to access Genoox\u2019s cloud-based AI platform, Franklin, with the launch of CytoScan Automated Interpretation and Reporting (AIR) solution, making cytogenetic research data analysis easier.\n<\/p>\n

<\/a><\/p>\n

\nBy automating interpretation and reporting, ChAS with Franklin provides an intuitive and flexible workflow for instant access to consistent, reproducible cytogenetic analysis results. While manual interpretation can take hours, ChAS users can now get accurate results in just seconds.\n<\/p>\n

\n\u201cWe developed ChAS software with input from leading cytogeneticists and continue to work with our customers to make data simpler and more intuitive,\u201d said Chad Carter, vice president and general manager, microarrays genetic solutions, Thermo Fisher Scientific. \u201cBy collaborating with Genoox, we can make data interpretation even easier so our customers can focus on their research.\u201d\n<\/p>\n

\n\u201cWe are excited to partner with Thermo Fisher Scientific, a leader in cytogenetics,\u201d said Amir Trabelsi, CEO and co-founder of Genoox. \u201cWe created Franklin to advance genomic medicine by giving users access to real world, real time genomic data. The combination of ChAS with Franklin continues this mission and we look forward to opening the platform to ChAS users.\u201d\n<\/p>\n

\nAbout Genoox<\/b>\n<\/p>\n

\nGenoox harnesses the power of its community to enable actionable insights from the largest real time-real life genomic database serving professionals at the point of care. Genoox\u2019s cloud-based AI platform, Franklin, connects clinicians, genetic counselors and healthcare organizations, while enabling platform users to make impactful discoveries using the most advanced genomic tools and applications. Genoox is used by over 2,100 health organizations, hospitals and medical facilities in 46 markets across the globe. Visit our website for more information at: www.genoox.com<\/a>.\n<\/p>\n

\nAbout Thermo Fisher Scientific<\/b>\n<\/p>\n

\nThermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nGENOOX PR
\n
PR@Genoox.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

PALO ALTO, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific has upgraded its leading Applied Biosystems Chromosome Analysis Suite (ChAS) software through a collaboration with Genoox, a community-driven genomic data company. ChAS users will be able to access Genoox\u2019s cloud-based AI platform, Franklin, with the launch of CytoScan Automated Interpretation and Reporting (AIR) solution, making cytogenetic research data analysis … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50173","6":"format-standard","7":"category-industry"},"yoast_head":"\nGenoox partners with Thermo Fisher Scientific to automate cytogenetic research data interpretation and reporting with AI - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genoox partners with Thermo Fisher Scientific to automate cytogenetic research data interpretation and reporting with AI - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PALO ALTO, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific has upgraded its leading Applied Biosystems Chromosome Analysis Suite (ChAS) software through a collaboration with Genoox, a community-driven genomic data company. ChAS users will be able to access Genoox\u2019s cloud-based AI platform, Franklin, with the launch of CytoScan Automated Interpretation and Reporting (AIR) solution, making cytogenetic research data analysis ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-27T14:02:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221026005577\/en\/1614581\/21\/Genoox.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Genoox partners with Thermo Fisher Scientific to automate cytogenetic research data interpretation and reporting with AI\",\"datePublished\":\"2022-10-27T14:02:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\\\/\"},\"wordCount\":432,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026005577\\\/en\\\/1614581\\\/21\\\/Genoox.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\\\/\",\"name\":\"Genoox partners with Thermo Fisher Scientific to automate cytogenetic research data interpretation and reporting with AI - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026005577\\\/en\\\/1614581\\\/21\\\/Genoox.jpg\",\"datePublished\":\"2022-10-27T14:02:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026005577\\\/en\\\/1614581\\\/21\\\/Genoox.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221026005577\\\/en\\\/1614581\\\/21\\\/Genoox.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genoox partners with Thermo Fisher Scientific to automate cytogenetic research data interpretation and reporting with AI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Genoox partners with Thermo Fisher Scientific to automate cytogenetic research data interpretation and reporting with AI - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/","og_locale":"en_US","og_type":"article","og_title":"Genoox partners with Thermo Fisher Scientific to automate cytogenetic research data interpretation and reporting with AI - Pharma Trend","og_description":"PALO ALTO, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific has upgraded its leading Applied Biosystems Chromosome Analysis Suite (ChAS) software through a collaboration with Genoox, a community-driven genomic data company. ChAS users will be able to access Genoox\u2019s cloud-based AI platform, Franklin, with the launch of CytoScan Automated Interpretation and Reporting (AIR) solution, making cytogenetic research data analysis ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-27T14:02:08+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221026005577\/en\/1614581\/21\/Genoox.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Genoox partners with Thermo Fisher Scientific to automate cytogenetic research data interpretation and reporting with AI","datePublished":"2022-10-27T14:02:08+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/"},"wordCount":432,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221026005577\/en\/1614581\/21\/Genoox.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/","url":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/","name":"Genoox partners with Thermo Fisher Scientific to automate cytogenetic research data interpretation and reporting with AI - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221026005577\/en\/1614581\/21\/Genoox.jpg","datePublished":"2022-10-27T14:02:08+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221026005577\/en\/1614581\/21\/Genoox.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221026005577\/en\/1614581\/21\/Genoox.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/genoox-partners-with-thermo-fisher-scientific-to-automate-cytogenetic-research-data-interpretation-and-reporting-with-ai\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Genoox partners with Thermo Fisher Scientific to automate cytogenetic research data interpretation and reporting with AI"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50173","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50173"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50173\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50173"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50173"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}